DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
UB-312 Injection ( DrugBank: - )
2 diseases
告示番号
疾患名
(ページ内リンク)
臨床試験数
6
パーキンソン病
1
17
多系統萎縮症
1
6. パーキンソン病
臨床試験数
:
2,307
/
薬物数
:
2,007
- (
DrugBank
:
349
) /
標的遺伝子数
:
188
-
標的パスウェイ数
:
199
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT05634876
(
ClinicalTrials.gov
)
April 2023
23/11/2022
UB-312 in Patients With Synucleinopathies
A Phase 1b Clinical Trial of UB-312 in Patients With Synucleinopathies
Multiple System Atrophy;Parkinson Disease
Biological:
UB-312 Injection
;Biological: Placebo Injection
NYU Langone Health
NULL
Not yet recruiting
40 Years
75 Years
All
8
Phase 1/Phase 2
United States
17. 多系統萎縮症
臨床試験数
:
119
/
薬物数
:
138
- (
DrugBank
:
44
) /
標的遺伝子数
:
59
-
標的パスウェイ数
:
111
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT05634876
(
ClinicalTrials.gov
)
April 2023
23/11/2022
UB-312 in Patients With Synucleinopathies
A Phase 1b Clinical Trial of UB-312 in Patients With Synucleinopathies
Multiple System Atrophy;Parkinson Disease
Biological:
UB-312 Injection
;Biological: Placebo Injection
NYU Langone Health
NULL
Not yet recruiting
40 Years
75 Years
All
8
Phase 1/Phase 2
United States